STXBP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.072000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.298800E-01
Normal-vs-Stage2
6.276000E-01
Normal-vs-Stage3
2.598200E-01
Normal-vs-Stage4
9.426000E-01
Stage1-vs-Stage2
1.476960E-01
Stage1-vs-Stage3
2.225800E-02
Stage1-vs-Stage4
5.951400E-01
Stage2-vs-Stage3
1.165710E-04
Stage2-vs-Stage4
5.170800E-01
Stage3-vs-Stage4
2.153700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.920400E-01
Normal-vs-AfricanAmerican
7.848400E-01
Normal-vs-Asian
3.835000E-01
Caucasian-vs-AfricanAmerican
2.489200E-01
Caucasian-vs-Asian
4.017600E-01
AfricanAmerican-vs-Asian
1.783760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.750600E-01
Normal-vs-Female
6.278600E-01
Male-vs-Female
6.079400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.264000E-01
Normal-vs-Age(41-60Yrs)
9.890000E-01
Normal-vs-Age(61-80Yrs)
6.308200E-01
Normal-vs-Age(81-100Yrs)
1.027570E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.718400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.499200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.548380E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.222100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.922600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.402300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.827800E-01
Normal-vs-Daily Drinker
2.797400E-01
Normal-vs-Weekly Drinker
3.237600E-01
Normal-vs-Occasional Drinker
9.167200E-01
Normal-vs-Social Drinker
9.890800E-01
Non Drinker-vs-Daily Drinker
2.910200E-02
Non Drinker-vs-Weekly Drinker
8.526600E-01
Non Drinker-vs-Occasional Drinker
1.261790E-01
Non Drinker-vs-Social Drinker
1.678020E-01
Daily Drinker-vs-Weekly Drinker
1.892410E-01
Daily Drinker-vs-Occasional Drinker
1.507540E-02
Daily Drinker-vs-Social Drinker
1.819820E-02
Weekly Drinker-vs-Occasional Drinker
1.302030E-01
Weekly Drinker-vs-Social Drinker
1.767980E-01
Occasional Drinker-vs-Social Drinker
8.266400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.114000E-01
Normal-vs-Grade 2
8.730400E-02
Normal-vs-Grade 3
6.219600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.526800E-01
Grade 1-vs-Grade 3
3.629600E-01
Grade 1-vs-Grade 4
1.114000E-01
Grade 2-vs-Grade 3
7.130600E-01
Grade 2-vs-Grade 4
8.730400E-02
Grade 3-vs-Grade 4
6.219600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.809600E-01
Normal-vs-NonDiabetic
6.614000E-01
Diabetic-vs-NonDiabetic
4.526000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.717800E-01
Normal-vs-NoPancreatitis
6.808400E-01
Pancreatitis-vs-NoPancreatitis
3.068200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.860800E-01
Normal-vs-N1
6.959400E-01
N0-vs-N1
8.623200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.516200E-01
Normal-vs-TP53-NonMutant
8.561400E-01
TP53-Mutant-vs-TP53-NonMutant
4.516100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
